3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Recruiting
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Breast Neoplasms
16
Neoplasms
14
Prostatic Neoplasms
10
Hematologic Neoplasms
9
Colorectal Neoplasms
8
Lung Neoplasms
5
Hematopoietic and Lymphatic System Neoplasm
5
Squamous Cell Carcinoma of Head and Neck
4
Anatomic Stage I Breast Cancer AJCC v8
4
Triple Negative Breast Neoplasms
3
Pancreatic Neoplasms
3
Neoplasm Metastasis
3
Mouth Neoplasms
3
Melanoma
3
Malignant Solid Neoplasm
3
Leukemia, Myeloid, Acute
3
Head and Neck Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Urinary Bladder Neoplasms
2
Sarcoma
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Parotid Neoplasms
2
Ovarian Neoplasms
2
Oropharyngeal Neoplasms
2
Head and Neck Carcinoma
2
Glioma
2
Carcinoma, Squamous Cell
2
Carcinoma, Renal Cell
2
Carcinoma, Basal Cell
2
COVID-19
2
Interventions
Paclitaxel
6
Mitomycin
3
Carboplatin
3
Bevacizumab
3
sodium thiosulfate
2
Laparoscopy
2
Hyperthermic Intraperitoneal Chemotherapy
2
Cisplatin
2
relacorilant
1
pembrolizumab
1
oregovomab
1
olaparib
1
nilotinib
1
liposomal doxorubicin
1
Topotecan
1
Taxes
1
Standard of Care
1
Specimen Handling
1
Saline Solution
1
Practice Guidelines as Topic
1
Pancreatectomy
1
Oxaliplatin
1
Magnetic Resonance Spectroscopy
1
Laparotomy
1
Glucose
1
Gemcitabine
1
Fluorouracil
1
Electrocardiography
1
Doxorubicin
1
Docetaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Peritoneal Neoplasms
×
Standard of Care
×
90 days
×
Clear all
NCT07001748
2026-05-15
STOPGAP II
Eastern Cooperative Oncology Group
Phase 2/3
Recruiting
148 enrolled